FILE:MDT/MDT-8K-20060124190319.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
Table of Contents
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
Table of Contents
Item 8.01. Other Events.
On January 23, 2006, Medtronic, Inc. issued the press release filed herewith as Exhibit 99.1 and incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
Exhibit 99.1 Press release dated January 23, 2006.
Table of Contents
      Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Table of Contents

 
Exhibit 99.1
FOR IMMEDIATE RELEASE
Medtronic Extends Its Exchange Offer for 4.375 Percent Senior Notes Due 2010 and 4.750 Percent Senior Notes Due 2015
 Medtronic, Inc. (NYSE: MDT) announced today that it has extended its pending exchange offer relating to an aggregate of up to $1 billion of its outstanding 4.375 percent Senior Notes due 2010 and 4.750 percent Senior Notes due 2015 (collectively the "Old Notes"). The expiration date for the exchange offer has been extended from midnight, EST on Jan. 23, 2006 to midnight, EST on Feb. 10, 2006, unless further extended. As of 5:00 p.m. EST on Friday Jan. 20, 2006, approximately $974.5 million in aggregate principal amount of the Old Notes, or 97.4 percent of all outstanding Old Notes, had been tendered into the exchange offer.
Minneapolis, January 23, 2006
In the exchange offer, Medtronic is offering to exchange $2,000 principal amount and integral amounts of $1,000 of its newly issued 4.375 percent Senior Notes, Series B due 2010 and 4.750 percent Senior Notes, Series B due 2015 (collectively the "New Notes"), for each $2,000 principal amount and integral amounts of $1,000 of its respective outstanding Old Notes. Tenders of Old Notes may be withdrawn at any time prior to the expiration date.
The full terms of the exchange offer and a description of the New Notes and other information relating to the exchange offer and Medtronic are set forth in the registration statement and prospectus included therein filed with the Securities and Exchange Commission on December 6, 2005.
 
Wells Fargo Bank, National Association is the exchange agent for the exchange and offer and trustee of the New Notes. Copies of the prospectus and related letter of transmittal may be obtained from Wells Fargo at the address and telephone number as follows:
Wells Fargo Bank, N.A. Corporate Trust & Escrow Services N9303-110 MAC Sixth and Marquette Minneapolis, MN 55479 Attention: Steven R. Gubrud (612) 667-9090
A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION BUT HAS NOT YET BECOME EFFECTIVE. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT BECOMES EFFECTIVE. THIS PRESS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALES OF THESE SECURITIES IN ANY STATE OR JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH STATE OR JURISDICTION.
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology  alleviating pain, restoring health, and extending life for millions of people around the world.


